6AR0 image
Deposition Date 2017-08-21
Release Date 2018-07-04
Last Version Date 2023-10-04
Entry Detail
PDB ID:
6AR0
Title:
Structure of human SLMAP FHA domain
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.08 Å
R-Value Free:
0.17
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Sarcolemmal membrane-associated protein
Gene (Uniprot):SLMAP
Chain IDs:A
Chain Length:140
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
Elife 6 ? ? (2017)
PMID: 29063833 DOI: 10.7554/eLife.30278

Abstact

The Hippo pathway controls tissue growth and homeostasis through a central MST-LATS kinase cascade. The scaffold protein SAV1 promotes the activation of this kinase cascade, but the molecular mechanisms remain unknown. Here, we discover SAV1-mediated inhibition of the PP2A complex STRIPAKSLMAP as a key mechanism of MST1/2 activation. SLMAP binding to autophosphorylated MST2 linker recruits STRIPAK and promotes PP2A-mediated dephosphorylation of MST2 at the activation loop. Our structural and biochemical studies reveal that SAV1 and MST2 heterodimerize through their SARAH domains. Two SAV1-MST2 heterodimers further dimerize through SAV1 WW domains to form a heterotetramer, in which MST2 undergoes trans-autophosphorylation. SAV1 directly binds to STRIPAK and inhibits its phosphatase activity, protecting MST2 activation-loop phosphorylation. Genetic ablation of SLMAP in human cells leads to spontaneous activation of the Hippo pathway and alleviates the need for SAV1 in Hippo signaling. Thus, SAV1 promotes Hippo activation through counteracting the STRIPAKSLMAP PP2A phosphatase complex.

Legend

Protein

Chemical

Disease

Primary Citation of related structures